PART I Unless the context otherwise requires, references in this Business section to ADMA, ADMA Biologics, the Company, we, us and our refer to ADMA Biologics, Inc., a Delaware corporation, as well as its wholly owned subsidiaries, ADMA BioManufacturing, LLC, a Delaware limited liability company (ADMA BioManufacturing), ADMA BioCenters Georgia Inc., a Delaware corporation (ADMA BioCenters) and ADMA Plasma Biologics, Inc., a Delaware corporation (ADMA Plasma Biologics). Overview We are a U.S. bas...
Q2 FY2026 — expected 2026-08-05
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-25 | 2025-12-31 | 0001140361-26-006815 | EDGAR | 90K words |
| 2025-03-18 | 2024-12-31 | 0001140361-25-009257 | EDGAR | — |
| 2024-02-28 | 2023-12-31 | 0001140361-24-010147 | EDGAR | — |
| 2023-03-23 | 2022-12-31 | 0001140361-23-013467 | EDGAR | — |
| 2022-03-24 | 2021-12-31 | 0001140361-22-011030 | EDGAR | — |
| 2021-03-25 | 2020-12-31 | 0001193805-21-000411 | EDGAR | — |
| 2020-03-13 | 2019-12-31 | 0001193805-20-000348 | EDGAR | — |
| 2019-03-13 | 2018-12-31 | 0001193805-19-000281 | EDGAR | — |
| 2018-03-29 | 2017-12-31 | 0001193805-18-000470 | EDGAR | — |
| 2017-02-24 | 2016-12-31 | 0001193805-17-000330 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-05 | 2025-09-30 | 0001140361-25-040578 | EDGAR | 50K words |
| 2025-08-06 | 2025-06-30 | 0001140361-25-029177 | EDGAR | — |
| 2025-05-07 | 2025-03-31 | 0001140361-25-017747 | EDGAR | — |
| 2024-11-07 | 2024-09-30 | 0001140361-24-045693 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0001140361-24-036432 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0001140361-24-025226 | EDGAR | — |
| 2023-11-08 | 2023-09-30 | 0001140361-23-052109 | EDGAR | — |
| 2023-08-09 | 2023-06-30 | 0001140361-23-038843 | EDGAR | — |
| 2023-05-10 | 2023-03-31 | 0001140361-23-023920 | EDGAR | — |
| 2022-11-09 | 2022-09-30 | 0001140361-22-040738 | EDGAR | — |
| 2022-08-10 | 2022-06-30 | 0001140361-22-029116 | EDGAR | — |
| 2022-05-11 | 2022-03-31 | 0001140361-22-018668 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-27 | 0001140361-26-011569 | EDGAR | 3K words |
| 2026-03-02 | 0001140361-26-007230 | EDGAR | — |
| 2026-02-25 | 0001140361-26-006781 | EDGAR | — |
| 2026-01-12 | 0001140361-26-000906 | EDGAR | — |
| 2025-11-05 | 0001140361-25-040539 | EDGAR | — |
| 2025-08-06 | 0001140361-25-029143 | EDGAR | — |
| 2025-06-04 | 0001140361-25-021440 | EDGAR | — |
| 2025-05-07 | 0001140361-25-017704 | EDGAR | — |
| 2025-04-28 | 0001140361-25-015881 | EDGAR | — |
| 2025-03-03 | 0001140361-25-006745 | EDGAR | — |
394 total filings indexed. 362 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001368514 |
| Ticker | ADMA |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.admabiologics.com |
| Listed | 2013-10-17 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report